Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BZUN
1001
PUT
Baozun
BZUN
$165M
| $33.8M | 0.01% |
878,400
+455,200
| +108% | +$14.3M |
|
1002
CALL
Novartis
NVS
$287B
| $33.8M | 0.01% |
386,600
+61,200
| +19% | +$5.28M |
|
1003
CALL
State Street SPDR S&P Retail ETF
XRT
$640M
| $33.7M | 0.01% |
786,500
+487,000
| +163% | +$18.5M |
|
1004
Enbridge
ENB
$111B
| $33.7M | 0.01% |
1,108,230
-654,748
| -37% | -$20.1M |
|
1005
iShares MSCI India ETF
INDA
$6.56B
| $33.7M | 0.01% |
1,161,332
+1,093,855
| +1,621% | +$29.3M |
|
|
NEWR
1006
DELISTED
New Relic, Inc.
NEWR
| $33.7M | 0.01% |
488,647
-209,783
| -30% | -$12.5M |
|
1007
Popular Inc
BPOP
$11.3B
| $33.5M | 0.01% |
902,204
+316,673
| +54% | +$11.8M |
|
1008
Aramark
ARMK
$16.4B
| $33.5M | 0.01% |
+2,056,546
| New | +$36.1M |
|
1009
Federated Hermes
FHI
$4.79B
| $33.5M | 0.01% |
1,412,670
+523,082
| +59% | +$11.6M |
|
1010
CALL
Vanguard Real Estate ETF
VNQ
$39.2B
| $33.5M | 0.01% |
426,100
-17,600
| -4% | -$1.33M |
|
1011
CALL
Nucor
NUE
$61B
| $33.4M | 0.01% |
807,300
+390,500
| +94% | +$15.8M |
|
|
1012
PUT
State Street SPDR S&P Retail ETF
XRT
$640M
| $33.2M | 0.01% |
775,000
-231,100
| -23% | -$8.77M |
|
1013
Penumbra
PEN
$12.9B
| $33.2M | 0.01% |
185,712
+157,818
| +566% | +$27.4M |
|
|
IRBT
1014
CALL
DELISTED
iRobot
IRBT
| $33.1M | 0.01% |
395,100
-53,300
| -12% | -$3.51M |
|
1015
Zymeworks
ZYME
$1.78B
| $33.1M | 0.01% |
918,450
+492,964
| +116% | +$18.2M |
|
|
BPMC
1016
DELISTED
Blueprint Medicines
BPMC
| $33.1M | 0.01% |
424,610
-21,457
| -5% | -$1.45M |
|
1017
Corteva
CTVA
$51.2B
| $33M | 0.01% |
1,233,439
+233,771
| +23% | +$6.08M |
|
1018
Dana Inc
DAN
$3.26B
| $33M | 0.01% |
2,708,269
+973,491
| +56% | +$10.6M |
|
1019
Visa
V
$680B
| $32.9M | 0.01% |
170,423
+39,447
| +30% | +$7.21M |
|
|
TECX
1020
Tectonic Therapeutic
TECX
$682M
| $32.8M | 0.01% |
156,807
-6,083
| -4% | -$1.25M |
|
|
WWE
1021
DELISTED
World Wrestling Entertainment
WWE
| $32.8M | 0.01% |
753,989
+529,746
| +236% | +$22.7M |
|
|
K
1022
PUT
DELISTED
Kellanova
K
| $32.8M | 0.01% |
528,134
+155,490
| +42% | +$9.41M |
|
|
1023
PUT
Vanguard Real Estate ETF
VNQ
$39.2B
| $32.7M | 0.01% |
416,900
+152,000
| +57% | +$11.5M |
|
1024
US Foods
USFD
$23.6B
| $32.7M | 0.01% |
1,658,099
+1,212,428
| +272% | +$23.2M |
|
1025
AXIS Capital
AXS
$7.38B
| $32.7M | 0.01% |
805,379
-61,552
| -7% | -$2.37M |
|
Similar funds
Citadel Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Citadel Advisors held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Citadel Advisors withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Citadel Advisors opened a new position in Becton Dickinson worth $266M.
- Citadel Advisors's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Citadel Advisors added most to Amazon in Q2 2020, an estimated $861M increase.
- Citadel Advisors's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Citadel Advisors fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Citadel Advisors's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Citadel Advisors opened 1,506 new positions and closed 1,324 in Q2 2020.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.